Antimuscarinic agents: Implications and concerns in themanagement of overactive bladder in the elderly
Authors:
- Gary G. KayGKGary G. Kay
- Lisa J. GranvilleLGLisa J. Granville
- 1 January 2005
- journal article
- review article
- Published by Elsevier in Clinical Therapeutics
- Vol. 27 (1) , 127-138
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Drug Treatment of Overactive BladderDrugs, 2004
- Selective cognitive dysfunction in acetylcholine M1 muscarinic receptor mutant miceNature Neuroscience, 2002
- The standardisation of terminology of lower urinary tract function: Report from the standardisation sub‐committee of the International Continence SocietyNeurourology and Urodynamics, 2002
- A SHORT-TERM, MULTICENTER, RANDOMIZED DOUBLE-BLIND DOSE TITRATION STUDY OF THE EFFICACY AND ANTICHOLINERGIC SIDE EFFECTS OF TRANSDERMAL COMPARED TO IMMEDIATE RELEASE ORAL OXYBUTYNIN TREATMENT OF PATIENTS WITH URGE URINARY INCONTINENCEJournal of Urology, 2001
- Effects of Tolterodine, Trospium Chloride, and Oxybutynin on the Central Nervous SystemThe Journal of Clinical Pharmacology, 2001
- Aging and the Public Health Effects of DementiaNew England Journal of Medicine, 2001
- TolterodineDrugs & Aging, 2001
- Hopkins Verbal Learning Test – Revised: Normative Data and Analysis of Inter-Form and Test-Retest ReliabilityThe Clinical Neuropsychologist, 1998
- Functional role of M2 and M3 muscarinic receptors in the urinary bladder of rats in vitro and in vivoBritish Journal of Pharmacology, 1997
- The Problems of Anticholinergic Adverse Effects in Older PatientsDrugs & Aging, 1993